Dark

TARS
Tarsus Pharmaceuticals, Inc. Common Stock
stock NASDAQ

At Close

Dec 26, 2025 3:59:53 PM EST

81.75USD-0.915%(-0.76)240,994

0.00Bid 0.00Ask 0.00Spread

Pre-market

Dec 24, 2025 9:27:30 AM EST

82.03USD-0.582%(-0.48)0

After-hours

Dec 26, 2025 4:04:30 PM EST

80.99USD-0.936%(-0.76)2,446

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

3.47B

Industry

Biotechnology

TARS Stats

Avg. Vol. 10 Day

699,453

Avg. Vol. 30 Day

509,756

Employees

Market Cap

3,469,365,352

Shares Out.

42,449,105

On/Off Exchange

47%/53%

6 Month Beta

0.46

1 Year Beta

0.55

2 Year Beta

0.68

3 Year Beta

0.70

52 Week Low

38.51

52 Week High

85.25

SMA50

75.66

SMA200

55.43

1 Week

+0.41%

1 Month

+1.53%

3 Month

+45.20%

6 Month

+102.65%

1 Year

+50.38%

2 Year

+305.41%

5 Year

+104.33%

Profile

tarsus pharmaceuticals, inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. its lead product candidate is tp-03, a novel therapeutic that is in phase iib/iii for the treatment of blepharitis caused by the infestation of demodex mites, as well as to treat meibomian gland disease. the company is also developing tp-04 for the treatment of rosacea; and tp-05 for lyme prophylaxis and community malaria reduction. tarsus pharmaceuticals, inc. was founded in 2016 and is headquartered in irvine, california.

TARS Stock Summary

Tarsus Pharmaceuticals, Inc. Common Stock (NASDAQ:TARS) stock price today is $81.75, and today's volume is 240,994. TARS is down -0.915% today. The 30 day average volume is 509,756. TARS market cap is 3.47B with 42,449,105 shares outstanding.

.dark-mode .YYPBQC{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .YYPBQC{ color: #333333; background-color: white; border: 2px solid #333333; }TARSTarsus Pharmaceuticals, Inc. Common Stockstock NASDAQ

TARS Stock Summary

TARS
Tarsus Pharmaceuticals, Inc. Common Stock
stock NASDAQ